Started on January 2021, the 4 years Horizon 2020 BRAINTEASER project seeks to exploit the value of artificial intelligence, big data—including those related to health, lifestyle habits and environment—, low-cost sensors and smart apps to support patients living with amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS) and their caregivers. Its goal is to develop patient stratification and disease progression models to detect, alleviate and manage the negative impact induced by factors that contribute to the diseases cause, progression and survival. The BRAINTEASER multidisciplinary approach, guided by a strong focus on co-design methodologies, will pave the path for patients toward a healthier and more fulfilling life and will support the enhancement of public health systems’ capacities to adopt a more predictive and personalised approach to health.

The initial BRAINTEASER technical solution will be presented during the “Open co-design workshop on next generation tools to manage ALS and MS” workshop. External experts and the audience will be involved in a collaborative and participative discussion on clinical unmet needs, disease course, clinical practice and new emerging research on ALS and MS to assess the BRAINTEASER solution and propose possible refinements.

Click here to view workshop details, registration link and agenda.